Mark Hamann to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Mark Hamann has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.063
-
SPK-843 (Aparts/Kaken). Curr Opin Investig Drugs. 2005 Aug; 6(8):845-53.
Score: 0.063
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.